Recently, we reported that allicin treatment improved cardiac dysfunction and decreased hypertension, vascular reactivity to Ang II, and the oxidative stress in a way dependent on the Nrf2/Keap1 system [18]. This evidence concerns the gene KEAP1 and hypertensive disorder.